The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line panitumumab plus docetaxel and cisplatin in advanced gastric or gastroesophageal junction adenocarcinoma: Results of a phase II trial (SPIGA).
 
Guillermo Alfonso Quintero Aldana
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Roche
 
Sonia Candamio Folgar
Consulting or Advisory Role - Lilly; Roche
Travel, Accommodations, Expenses - Roche
 
Jose Carlos Méndez Méndez
No Relationships to Disclose
 
Margarita Reboredo
No Relationships to Disclose
 
Mónica Jorge Fernández
Consulting or Advisory Role - Bayer; Lilly; Sanofi
Speakers' Bureau - Amgen; Janssen-Cilag
Research Funding - Amgen; Celgene
Travel, Accommodations, Expenses - Amgen; Celgene; Merck; Roche
 
Manuel Constenla
No Relationships to Disclose
 
Carlos Romero Reinoso
No Relationships to Disclose
 
Mercedes Salgado Fernández
Consulting or Advisory Role - Amgen; Bayer; Celgene; Roche